Despite continued advances in laser and incisional surgery, medical therapy still appears to
be the primary means by which intraocular pressure is controlled. Initial medical therapy has …

In the last decade topically applied prostaglandin F2α analogues (bimatoprost, latanoprost,
travoprost and unoprostone) have become widely used as a means to reduce elevated …

PURPOSE: To Internet Advance publication at ajo. com Feb 13, 2003. compare the
intraocular pressure (IOP)-lowering effect and safety of latanoprost, bimatoprost, and …

PURPOSE: To study the effects of 3 prostaglandin analogs, bimatoprost, latanoprost, and
travoprost, on aqueous dynamics in the same subjects and to compare techniques of …

Objectives To investigate the effects of prostaglandin analogues on the blood-aqueous
barrier and to evaluate the occurrence of cystoid macular edema in aphakic or …

The ocular drug discovery field has evidenced significant advancement in the past decade.
The FDA approvals of Rhopressa, Vyzulta, and Roclatan for glaucoma, Brolucizumab for wet …

Purpose: To report a new adverse effect related to treatment with bimatoprost. Case Reports:
Serial clinical examination of three patients was performed. In each of the three reported …

Purpose To confirm the possible mechanism by which topical prostaglandin antiglaucoma
drugs cause a deep superior sulcus. Methods Among patients who used bimatoprost …

PURPOSE: To compare 24-hour reduction in intraocular pressure (IOP) by latanoprost
0.005%, travoprost 0.004%, and bimatoprost 0.03% in patients with primary open-angle …

Over the last 12 years, the pharmacological management of glaucoma and ocular
hypertension has significantly changed with the introduction of the prostaglandin analogs …